Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Cancer Management and Research Volume 13, 2021 - Issue

Submit an article Journal homepage

Open access

116

Views

CrossRef citations to date

Altmetric

Review

Optimal Management of Patients with Advanced or Metastatic Cholangiocarcinoma: An Evidence-Based Review

Dina Ioffe1 Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

Pooja Phull1 Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

Efrat Dotan1 Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USACorrespondence[email protected]

Pages 8085-8098 | Published online: 27 Oct 2021

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (8)

Najah Albadari, Yang Xie & Wei Li. (2024) Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling. Frontiers in Pharmacology 14.
Crossref

James E. Frampton. (2024) Pemigatinib: A Review in Advanced Cholangiocarcinoma. Targeted Oncology 19:1, pages 107-114.
Crossref

Justine Vancanneyt, Bie Wilmsen, Caroline Luyten, Chris Verslype, Eric Van Cutsem, Tania Roskams, Sabine Tejpar, Isabelle Vanden Bempt & Jeroen Dekervel. (2023) Therapeutic yield of extensive molecular profiling in cholangiocarcinoma: a retrospective single-center study. Journal of Cancer Research and Clinical Oncology 149:11, pages 9173-9181.
Crossref

Abduladheem Turki Jalil, Mohanad Ali Abdulhadi, Lubna R. Al-Ameer, Luay Ali Khaleel, Sada Jasim Abdulameer, Ameer Mezher Hadi, Muna. S Merza, Rahman S. Zabibah & Ahmed Ali. (2023) Small but mighty: How microRNAs drive the deadly progression of cholangiocarcinoma. Pathology - Research and Practice 247, pages 154565.
Crossref

Ingrid Garajová, Fabio Gelsomino, Massimiliano Salati, Francesco Leonardi, Stefania De Lorenzo, Alessandro Granito & Francesco Tovoli. (2023) Bone Metastases from Intrahepatic Cholangiocarcinoma Confer Worse Prognosis. Current Oncology 30:3, pages 2613-2624.
Crossref

Pierluigi Toniutto, Sarah Shalaby, Laura Mameli, Filomena Morisco, Martina Gambato, Valentina Cossiga, Maria Guarino, Fabio Marra, Maurizia R. Brunetto, Patrizia Burra & Erica Villa. (2023) Role of sex in liver tumor occurrence and clinical outcomes: a comprehensive review. Hepatology Publish Ahead of Print.
Crossref

Peixin Huang, Xiaoyong Huang, Yingting Zhou, Guohuan Yang, Qiman Sun, Guoming Shi & Yi Chen. (2022) The Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Based on FOLFIRI for Advanced Intrahepatic Cholangiocarcinoma as Second-Line and Successive Treatment: A Real-World Study. Canadian Journal of Gastroenterology and Hepatology 2022, pages 1-7.
Crossref

Lei Zhang, Donglai Ma, Fujun Li, Gongcai Qiu, Dongsheng Sun & Zhaolin Zeng. (2022) Lnc-PKD2-2-3/miR-328/GPAM ceRNA Network Induces Cholangiocarcinoma Proliferation, Invasion and 5-FU Chemoresistance. Frontiers in Oncology 12.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references